PDT Partners LLC raised its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 49.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 34,535 shares of the company's stock after buying an additional 11,455 shares during the quarter. PDT Partners LLC's holdings in DaVita were worth $5,283,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Stifel Financial Corp increased its holdings in shares of DaVita by 3.2% in the 4th quarter. Stifel Financial Corp now owns 5,937 shares of the company's stock valued at $888,000 after purchasing an additional 185 shares during the period. Beacon Pointe Advisors LLC acquired a new position in shares of DaVita in the 4th quarter valued at about $224,000. Northern Trust Corp increased its holdings in shares of DaVita by 12.5% in the 4th quarter. Northern Trust Corp now owns 740,774 shares of the company's stock valued at $110,783,000 after purchasing an additional 82,326 shares during the period. Lido Advisors LLC increased its holdings in shares of DaVita by 46.4% in the 4th quarter. Lido Advisors LLC now owns 2,718 shares of the company's stock valued at $406,000 after purchasing an additional 862 shares during the period. Finally, Schonfeld Strategic Advisors LLC increased its holdings in shares of DaVita by 91.2% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 20,915 shares of the company's stock valued at $3,128,000 after purchasing an additional 9,974 shares during the period. 90.12% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other DaVita news, insider James O. Hearty sold 2,351 shares of the stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the transaction, the insider owned 26,038 shares in the company, valued at $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.50% of the stock is currently owned by company insiders.
DaVita Stock Performance
DVA stock traded up $2.16 during midday trading on Friday, hitting $137.72. 659,996 shares of the company traded hands, compared to its average volume of 686,564. DaVita Inc. has a twelve month low of $126.07 and a twelve month high of $179.60. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. The business has a 50 day simple moving average of $139.40 and a 200-day simple moving average of $141.94. The stock has a market capitalization of $9.85 billion, a price-to-earnings ratio of 13.54, a price-to-earnings-growth ratio of 0.97 and a beta of 1.13.
DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, beating the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The company had revenue of $3.38 billion for the quarter, compared to the consensus estimate of $3.36 billion. During the same quarter last year, the company posted $2.00 earnings per share. The company's revenue for the quarter was up 6.1% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities research analysts predict that DaVita Inc. will post 10.76 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on DVA. Truist Financial set a $148.00 target price on DaVita in a report on Friday, August 8th. Barclays dropped their price objective on DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Finally, Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, August 22nd. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $164.00.
Check Out Our Latest Research Report on DaVita
DaVita Company Profile
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading
Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
